A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2004
12/29/2004	CN1557311A Fibrauretine capsule tablet and its preparation method
12/29/2004	CN1557304A Acetazolamide eye droplet and its application method in treating glaucoma
12/29/2004	CN1182129C Benzopyran derivatives having leukotriene-antagonistic action
12/29/2004	CN1181888C Stable recombination human alpha interferon liquid preparation and productive process thereof
12/29/2004	CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug
12/29/2004	CA2839930A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2839928A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2839898A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2839849A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2839847A1 Ophthalmic compositions containing a synergistic combination of two polymers
12/29/2004	CA2529860A1 Ophthalmic composition
12/29/2004	CA2529501A1 Rate controlled release of a pharmaceutical agent in a biodegradable device
12/29/2004	CA2526427A1 Clostridial toxins for treating eye disorders
12/28/2004	US6835846 Aliphatic compounds, process for their preparation and their usage
12/28/2004	US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835748 Treatment of ocular disorders
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835716 Bactericides, antiprotozoa agents
12/28/2004	US6835715 Mammalian dihydroouabain-like factor and therapeutic compositions
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	CA2120709C Enzyme-orthokeratology
12/23/2004	WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004	WO2004045563A3 Method of treatment of myocardial infarction
12/23/2004	WO2004009062A3 NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau
12/23/2004	US20040259945 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
12/23/2004	US20040259941 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259923 Compound useful as cellular adhesion protein and as antiedemic agent
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/23/2004	US20040259865 Laxative; adenosine receptor antagonist
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259796 Using a peptide
12/23/2004	US20040259202 Novel angiogenesis inhibitor
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040258782 Isolation of lutein from alfalfa
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258691 Treating psoriasis in a patient by administering a therapeutically effective amount of an antibody immunospecific for vetronectin receptor av beta 3; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3; cell adhesion
12/22/2004	EP1489186A1 Angiogenesis inhibitors
12/22/2004	EP1489076A1 Cyclic hemiacetal derivative and use thereof
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488789A1 Eye drops containing tetrazole derivative
12/22/2004	EP1487876A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/22/2004	EP1487872A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487829A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487783A2 Irreversible selective androgen receptor modulators and methods of use thereof
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487498A1 Topical composition comprising a cyclofructan, a carrier and a drug
12/22/2004	EP1487469A1 Co-beadlet of dha and rosemary and methods of use
12/22/2004	EP1487456A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
12/22/2004	EP1487444A1 Use of pyridyl amides as inhibitors of angiogenesis
12/22/2004	EP1487438A2 Compositions and methods for treating glaucoma and ocular hypertension
12/22/2004	EP1487437A1 Methods of treatment with selective ep4 receptor agonists
12/22/2004	EP1487431A1 Preventing and/or treating cardiovascular disease and/or associated heart failure
12/22/2004	EP1487430A1 Methods for treating diseases related to intraocular pressure
12/22/2004	EP1274408B1 Use of natural chrysanthone compounds having antiangiogenic activity
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	EP0817648B1 Vascular endothelial cell growth factor antagonists
12/22/2004	CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004	CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556707A Ophthalmologic treatment methods using selective iNOS inhibitors
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1555885A Application of leukin 1 acceptor antagonist in medicine for preventing and treating posterior cataract
12/22/2004	CN1555810A Eye brightening eye washing liquid and its preparation method
12/22/2004	CN1181070C Urea substituted imidazoquinolines
12/22/2004	CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004	CN1180780C Picroside-II as one new medicine for preventing and treating allergic and inflammatory diseases
12/22/2004	CN1180776C Gel type floxacin eye ointment
12/22/2004	CN1180772C Eye drops of diclofenac sodium
12/21/2004	US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics
12/21/2004	US6833389 Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections
12/21/2004	US6833379 As diuretic agent
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	US6833358 Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides
12/21/2004	US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin
12/21/2004	US6833349 Therapy for skin disorders; psoriasis
12/21/2004	US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic
12/16/2004	WO2004108945A2 Oligonucleotide modulation of cell adhesion
12/16/2004	WO2004108764A2 Connective tissue growth factor antibodies
12/16/2004	WO2004108724A1 Tricyclic compound
12/16/2004	WO2004108670A1 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure
12/16/2004	WO2004108669A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
12/16/2004	WO2004108215A1 Piperidinyl prostaglandin e analogs
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004108129A1 Stem cell invasion inhibitor

1 ... 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 ... 531